Projects per year
Personal profile
Education/Academic qualification
Doctor of Pharmacy, Université de Liège (ULg)
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 16 Similar Profiles
Thromboxane Receptors
Medicine & Life Sciences
Thromboxanes
Medicine & Life Sciences
Thromboxane A2
Medicine & Life Sciences
Anticoagulants
Medicine & Life Sciences
Pharmacology
Medicine & Life Sciences
Platelets
Chemical Compounds
torsemide
Medicine & Life Sciences
Blood Platelets
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2004 2020
BIOMED HUB-AVRI: Artériopathie et Valvulopathie Radio-Induites Un nouveau défi pour la médecine moderne
1/06/17 → 31/12/20
Project: Research
NANOHEART : Nanoparticules de Squalène-Adénosine pour le traitement des dommages cardiaques lors d'ischémie/reperfusion
1/02/17 → 31/01/20
Project: Research
Implication of microparticles in thrombosis associated with paroxysmal nocturnal hemoglobinuria
Chatelain, B., Chatelain, C. & Dogne, J.
1/12/13 → …
Project: Research
ATHERO: pharmacological evaluation of modulators of the arachidonic cascade in atherosclerosis
1/10/06 → …
Project: Research
Research Output 1996 2018
Betrixaban: Impact on routine and specific coagulation assays -Practical laboratory guidance
Siriez, R., Chatelain, B., Devel, P., Dogne, J-M., Douxfils, J., Mullier, F., Pochet, L., Vancraeynest, C., Gheldof, D., Evrard, J., Devroye, C. & Guldenpfennig, M. 10 May 2018 (Accepted/In press)Research output: Contribution to conference › Poster
Betrixaban: Impact on routine and specific coagulation assays -Practical laboratory guidance
Siriez, R., Chatelain, B., Devel, P., Dogne, J-M., Douxfils, J., Mullier, F., Pochet, L., Vancraeynest, C., Gheldof, D., Evrard, J., Guldenpfennig, M. & Devroye, C. 18 Jul 2018 (Accepted/In press)Research output: Contribution to conference › Poster
Betrixaban: Impact on routine and specific coagulation assays - Practical laboratory guidance
Siriez, R., Evrard, J., Dogne, J-M., Pochet, L., Gheldof, D., Chatelain, B., Vancraeynest, C., Devel, P., Guldenpfennig, M., Devroye, C., Mullier, F. & Douxfils, J. 24 Sep 2018Research output: Contribution to conference › Poster
File
Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide
Siriez, R., Evrard, J., Dogne, J-M., Pochet, L., Gheldof, D., Chatelain, B., Mullier, F. & Douxfils, J. 12 Jun 2018 In : Thrombosis and Haemostasis. 13 p.Research output: Contribution to journal › Article
File
Betrixaban: Impact on routine and specific coagulation assays - Practical laboratory guidance
Siriez, R., Evrard, J., Douxfils, J., Dogne, J-M., Mullier, F., Pochet, L., Gheldof, D., Chatelain, B., Vancraeynest, C., Devel, P., Guldenpfennig, M. & Devroye, C. 2 Feb 2018Research output: Contribution to conference › Poster
Prizes
Prix Léo Pharma Cancer & Thrombosis
Hélène Haguet (Recipient), Jonathan Douxfils (Recipient), François Mullier (Recipient) & Jean-Michel Dogne (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities 2015 2018
- 5 Oral presentation
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Christian Chatelain (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker), Dogne, J. (Speaker)9 Feb 2018
Activity: Talk or presentation › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Christian Chatelain (Speaker), Graux, C. (Speaker), Dogne, J. (Speaker)25 Feb 2017
Activity: Talk or presentation › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Christian Chatelain (Speaker), Graux, C. (Speaker), Dogne, J. (Speaker)28 Apr 2016
Activity: Talk or presentation › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Christian Chatelain (Speaker), Graux, C. (Speaker), Dogne, J. (Speaker)29 Jan 2016
Activity: Talk or presentation › Oral presentation
Risk of cardiovascular events associated with BCR-ABL TKI in leukemic population: a systematic review and meta-analysis
Douxfils, J. (Speaker), Haguet, H. (Speaker), Mullier, F. (Speaker), Christian Chatelain (Speaker), Graux, C. (Speaker), Dogne, J. (Speaker)Jun 2015
Activity: Talk or presentation › Oral presentation
Thesis
Analytical and clinical validation of sensitive assays for the diagnosis of immune heparin-induced thrombocytopenia
Author: Minet, V., 2017Supervisor: Dogne, J. (Supervisor), Mullier, F. (External person) (Co-Supervisor), Laloy, J. (Jury), Lucas, S. (Jury), Masereel, B. (Jury), Chatelain, M. (External person) (Jury), Hoylaerts, M. F. (External person) (Jury) & Tardy, B. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
C. canimorsus interferes with coagulation by proteolytic cleavage of human coagulation factor X
Author: Hack, K., 12 Aug 2016Supervisor: Cornelis, G. (Supervisor), Letesson, J. (President), Dogne, J. (Jury), Michiels, T. (External person) (Jury), Bogaerts, P. (External person) (Jury) & Chatelain, B. (External person) (Jury)
Student thesis: Doc types › Doctor of Sciences
Caractérisation structurale de la 5-lipoxygénase humaine et de son inhibition: support à la conception rationnelle d'inhibiteurs mixtes 5-LOX-COX-2
Author: Charlier, C., 15 Feb 2006Supervisor: Wouters, J. (Supervisor), Durant, F. (Co-Supervisor), Dogne, J. (Jury), Vercauteren, D. (Jury), Hennichart, J. (External person) (Jury) & Moureau, F. (External person) (Jury)
Student thesis: Doc types › Doctor of Sciences
File
Conception, synthèse et évaluation pharmacologique de dérivés originaux du torasémide à propriétés antagonistes du thromboxane A2 et inhibitrices de la thromboxane synthétase
Author: Dogné, J., 2000Supervisor: Masereel, B. (Supervisor)
Student thesis: Master types › Master
Design, synthesis and evaluation of coagulation FXIIa inhibitors as potential antithrombotic agents
Author: Bouckaert, C., 16 May 2017Supervisor: Lanners, S. (President), Pochet, L. (Supervisor), Dogne, J. (Co-Supervisor), De Tullio, P. (External person) (Jury), Chatelain, C. (External person) (Jury) & TEN CATE, H. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences